GlassScriptPhysician profile
Kim A Baker
NPI 1023141413
$2,318.97
in general payments reported to CMS, 2019-2025
10 companies · $196 in 2025
The $196 reported for 2025 was more than what a typical Pediatric Otolaryngology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2021: $82.52 · 2022: $14.12 · 2023: $1,791 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,473 · Food and Beverage: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,472.53 |
| Food and Beverage | $514.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,719.38 | 2019-2023 | Tula, Coblation, Halo |
| Medtronic, INC. | $196.30 | 2025 | Pteye Parathyroid Detection System |
| Acclarent, INC | $155.43 | 2019 | |
| Vifor Pharma, INC. | $82.52 | 2021 | |
| Supernus Pharmaceuticals, INC. | $43.89 | 2019 | |
| Abbvie INC. | $39.20 | 2023 | Botox |
| Pacira Pharmaceuticals Incorporated | $23.98 | 2023 | Iovera |
| Jazz Pharmaceuticals INC. | $23.72 | 2019 | |
| Preceptis Medical, INC. | $20.43 | 2023 | Hummingbird Tympanostomy Tube System |
| Olympus America INC. | $14.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.